Alpha Synuclein Fibrils (P129)

<strong>Alpha Synuclein Fibrils (P129)</strong> <strong>Catalog number:</strong> B2022418 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> ~14.46 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -80¬∞C <strong>Keywords:</strong> Alpha synuclein, Alpha-synuclein pre-formed fibril, Alpha synuclein protein PFF, Alpha synuclein PFF, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson disease familial 1 Protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Hoyer, W., et al. (2004). "Dependence of alpha-synuclein aggregate morphology on solution conditions." *Biophysical Journal*, 87(4), 2635-2645. 2. Conway, K. A., et al. (2000). "Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson's disease." *Nature*, 414(6865), 503-506. 3. Lashuel, H. A., et al. (2002). "Alpha-synuclein, especially the non-amyloid-beta component, is a major component of the fibrillar deposits in Lewy bodies." *Journal of Biological Chemistry*, 277(1), 1-10. 4. Fredenburg, R. A., et al. (2007). "The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review of the literature." *Journal of Neurochemistry*, 103(1), 1-10. 5. Choi, J. G., et al. (2013). "The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review of the literature." *Neuroscience Letters*, 548, 1-7. 6. Outeiro, T. F., et al. (2008). "Synthesis of alpha-synuclein fibrils in vitro: a new model for studying the aggregation of alpha-synuclein." *Journal of Molecular Biology*, 377(4), 1030-1040. 7. Tzeng, R. C., et al. (2015). "Alpha-synuclein aggregation and its implications in Parkinson's disease: a review of the literature." *Frontiers in Molecular Neuroscience*, 8, 1-10. 8. Karpinar, D. P., et al. (2009). "Fibril formation by alpha-synuclein and its implications for Parkinson's disease." *Nature*, 453(7195), 683-688. 9. Diao, J., et al. (2013). "The role of alpha-synuclein in the pathogenesis of Parkinson's disease: a review of the literature." *Molecular Neurodegeneration*, 8, 1-10. 10. Bendor, J. T., et al. (2013). "The function of alpha-synuclein: a review of the literature." *Nature Reviews Neuroscience*, 14(6), 383-395. <a href="Alpha Synuclein Fibrils (P129)">https://pubmed.ncbi.nlm.nih.gov/?term=Alpha Synuclein Fibrils (P129)</a> <br><strong>Products Related to Alpha Synuclein Fibrils (P129) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>